Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Journal subject
Affiliation country
Publication year range
1.
Nucleic Acids Res ; 35(16): 5474-86, 2007.
Article in English | MEDLINE | ID: mdl-17702765

ABSTRACT

The MBNL and CELF proteins act antagonistically to control the alternative splicing of specific exons during mammalian postnatal development. This process is dysregulated in myotonic dystrophy because MBNL proteins are sequestered by (CUG)n and (CCUG)n RNAs expressed from mutant DMPK and ZNF9 genes, respectively. While these observations predict that MBNL proteins have a higher affinity for these pathogenic RNAs versus their normal splicing targets, we demonstrate that MBNL1 possesses comparably high affinities for (CUG)n and (CAG)n RNAs as well as a splicing target, Tnnt3. Mapping of a MBNL1-binding site upstream of the Tnnt3 fetal exon indicates that a preferred binding site for this protein is a GC-rich RNA hairpin containing a pyrimidine mismatch. To investigate how pathogenic RNAs sequester MBNL1 in DM1 cells, we used a combination of chemical/enzymatic structure probing and electron microscopy to determine that MBNL1 forms a ring-like structure which binds to the dsCUG helix. While the MBNL1 N-terminal region is required for RNA binding, the C-terminal region mediates homotypic interactions which may stabilize intra- and/or inter-ring interactions. Our results provide a mechanistic basis for dsCUG-induced MBNL1 sequestration and highlight a striking similarity in the binding sites for MBNL proteins on splicing precursor and pathogenic RNAs.


Subject(s)
Alternative Splicing , RNA Precursors/chemistry , RNA, Messenger/chemistry , RNA-Binding Proteins/metabolism , Trinucleotide Repeat Expansion , Animals , Base Sequence , Binding Sites , Cell Line , GC Rich Sequence , Gene Expression Regulation, Developmental , Humans , Introns , Mice , Molecular Sequence Data , Myotonic Dystrophy/genetics , RNA Precursors/metabolism , RNA Precursors/ultrastructure , RNA, Double-Stranded/chemistry , RNA, Double-Stranded/metabolism , RNA, Messenger/metabolism , RNA, Messenger/ultrastructure , RNA-Binding Proteins/chemistry , RNA-Binding Proteins/ultrastructure , Troponin T/genetics
2.
Dev Dyn ; 233(3): 783-93, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15830352

ABSTRACT

Cardiac troponin T (cTNT) exon 5 splicing is developmentally regulated such that it is included in embryonic but not adult heart. CUG-BP and ETR-3-like factor (CELF) proteins promote exon inclusion, whereas polypyrimidine tract binding protein (PTB) and muscleblind-like (MBNL) proteins repress inclusion. In this study, we addressed what happens to these regulatory proteins during heart development to shift the regulatory balance of cTNT alternative splicing. Using dominant-negative proteins, we found that both CELF and PTB activities are required for appropriate splicing in cardiomyocytes. Two CELF proteins, CUG-BP and ETR-3, are nuclear and cytoplasmic in embryonic heart but are down-regulated in adult heart concomitant with loss of exon inclusion. In contrast, PTB and MBNL1 are expressed throughout heart development. The patterns of cTNT splicing and expression of its regulatory factors are conserved between mouse and chicken. Thus, alternative splicing is determined by a balance between positive and negative regulation, and modulation of expression levels of auxiliary splicing regulators may drive developmental splicing changes. ETR-3 and CUG-BP proteins are also down-regulated in other tissues during development, suggesting that CELF proteins play a broad role in developmental splicing regulation.


Subject(s)
Alternative Splicing/genetics , Gene Expression Regulation, Developmental , Heart/embryology , Myocardium/metabolism , RNA Precursors/genetics , RNA Precursors/metabolism , Aging/physiology , Animals , Brain/metabolism , Cell Nucleus/genetics , Down-Regulation/genetics , Exons/genetics , Heart/growth & development , Mice , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism , Spleen/metabolism , Tongue/metabolism , Troponin T/genetics
SELECTION OF CITATIONS
SEARCH DETAIL